The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dexrazoxane for Injection Market Research Report 2025
Synopsis
An anti-tumor adjuvant drug that can be used to alleviate or reduce the myocardial toxicity caused by anthracycline antibiotics (such as doxorubicin) chemotherapy
Global Dexrazoxane for Injection market is projected to reach US$ 2518.7 million in 2029, increasing from US$ 1720 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dexrazoxane for Injection market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Dexrazoxane for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Jiangsu Aosaikang Pharma
Chaiatai Tianqing
Hairun Pharma
Kissei Pharma
Gland Pharma
Eugia Pharma
Hikma Pharma
Clinigen Group
Pfizer
Aurobindo Pharma
Segment by Type
250mg
500mg
Other
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Dexrazoxane for Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
An anti-tumor adjuvant drug that can be used to alleviate or reduce the myocardial toxicity caused by anthracycline antibiotics (such as doxorubicin) chemotherapy
Global Dexrazoxane for Injection market is projected to reach US$ 2518.7 million in 2029, increasing from US$ 1720 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dexrazoxane for Injection market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Dexrazoxane for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Jiangsu Aosaikang Pharma
Chaiatai Tianqing
Hairun Pharma
Kissei Pharma
Gland Pharma
Eugia Pharma
Hikma Pharma
Clinigen Group
Pfizer
Aurobindo Pharma
Segment by Type
250mg
500mg
Other
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Dexrazoxane for Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Dexrazoxane for Injection Market Overview
1.1 Product Overview and Scope of Dexrazoxane for Injection
1.2 Dexrazoxane for Injection Segment by Type
1.2.1 Global Dexrazoxane for Injection Market Value Comparison by Type (2023-2029)
1.2.2 250mg
1.2.3 500mg
1.2.4 Other
1.3 Dexrazoxane for Injection Segment by Application
1.3.1 Global Dexrazoxane for Injection Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Dexrazoxane for Injection Market Size Estimates and Forecasts
1.4.1 Global Dexrazoxane for Injection Revenue 2018-2029
1.4.2 Global Dexrazoxane for Injection Sales 2018-2029
1.4.3 Global Dexrazoxane for Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Dexrazoxane for Injection Market Competition by Manufacturers
2.1 Global Dexrazoxane for Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Dexrazoxane for Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Dexrazoxane for Injection Average Price by Manufacturers (2018-2023)
2.4 Global Dexrazoxane for Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Dexrazoxane for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dexrazoxane for Injection, Product Type & Application
2.7 Dexrazoxane for Injection Market Competitive Situation and Trends
2.7.1 Dexrazoxane for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dexrazoxane for Injection Players Market Share by Revenue
2.7.3 Global Dexrazoxane for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dexrazoxane for Injection Retrospective Market Scenario by Region
3.1 Global Dexrazoxane for Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Dexrazoxane for Injection Global Dexrazoxane for Injection Sales by Region: 2018-2029
3.2.1 Global Dexrazoxane for Injection Sales by Region: 2018-2023
3.2.2 Global Dexrazoxane for Injection Sales by Region: 2024-2029
3.3 Global Dexrazoxane for Injection Global Dexrazoxane for Injection Revenue by Region: 2018-2029
3.3.1 Global Dexrazoxane for Injection Revenue by Region: 2018-2023
3.3.2 Global Dexrazoxane for Injection Revenue by Region: 2024-2029
3.4 North America Dexrazoxane for Injection Market Facts & Figures by Country
3.4.1 North America Dexrazoxane for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Dexrazoxane for Injection Sales by Country (2018-2029)
3.4.3 North America Dexrazoxane for Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dexrazoxane for Injection Market Facts & Figures by Country
3.5.1 Europe Dexrazoxane for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Dexrazoxane for Injection Sales by Country (2018-2029)
3.5.3 Europe Dexrazoxane for Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dexrazoxane for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Dexrazoxane for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Dexrazoxane for Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Dexrazoxane for Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dexrazoxane for Injection Market Facts & Figures by Country
3.7.1 Latin America Dexrazoxane for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Dexrazoxane for Injection Sales by Country (2018-2029)
3.7.3 Latin America Dexrazoxane for Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dexrazoxane for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Dexrazoxane for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Dexrazoxane for Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Dexrazoxane for Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dexrazoxane for Injection Sales by Type (2018-2029)
4.1.1 Global Dexrazoxane for Injection Sales by Type (2018-2023)
4.1.2 Global Dexrazoxane for Injection Sales by Type (2024-2029)
4.1.3 Global Dexrazoxane for Injection Sales Market Share by Type (2018-2029)
4.2 Global Dexrazoxane for Injection Revenue by Type (2018-2029)
4.2.1 Global Dexrazoxane for Injection Revenue by Type (2018-2023)
4.2.2 Global Dexrazoxane for Injection Revenue by Type (2024-2029)
4.2.3 Global Dexrazoxane for Injection Revenue Market Share by Type (2018-2029)
4.3 Global Dexrazoxane for Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Dexrazoxane for Injection Sales by Application (2018-2029)
5.1.1 Global Dexrazoxane for Injection Sales by Application (2018-2023)
5.1.2 Global Dexrazoxane for Injection Sales by Application (2024-2029)
5.1.3 Global Dexrazoxane for Injection Sales Market Share by Application (2018-2029)
5.2 Global Dexrazoxane for Injection Revenue by Application (2018-2029)
5.2.1 Global Dexrazoxane for Injection Revenue by Application (2018-2023)
5.2.2 Global Dexrazoxane for Injection Revenue by Application (2024-2029)
5.2.3 Global Dexrazoxane for Injection Revenue Market Share by Application (2018-2029)
5.3 Global Dexrazoxane for Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Jiangsu Aosaikang Pharma
6.1.1 Jiangsu Aosaikang Pharma Corporation Information
6.1.2 Jiangsu Aosaikang Pharma Description and Business Overview
6.1.3 Jiangsu Aosaikang Pharma Dexrazoxane for Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Jiangsu Aosaikang Pharma Dexrazoxane for Injection Product Portfolio
6.1.5 Jiangsu Aosaikang Pharma Recent Developments/Updates
6.2 Chaiatai Tianqing
6.2.1 Chaiatai Tianqing Corporation Information
6.2.2 Chaiatai Tianqing Description and Business Overview
6.2.3 Chaiatai Tianqing Dexrazoxane for Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Chaiatai Tianqing Dexrazoxane for Injection Product Portfolio
6.2.5 Chaiatai Tianqing Recent Developments/Updates
6.3 Hairun Pharma
6.3.1 Hairun Pharma Corporation Information
6.3.2 Hairun Pharma Description and Business Overview
6.3.3 Hairun Pharma Dexrazoxane for Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Hairun Pharma Dexrazoxane for Injection Product Portfolio
6.3.5 Hairun Pharma Recent Developments/Updates
6.4 Kissei Pharma
6.4.1 Kissei Pharma Corporation Information
6.4.2 Kissei Pharma Description and Business Overview
6.4.3 Kissei Pharma Dexrazoxane for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kissei Pharma Dexrazoxane for Injection Product Portfolio
6.4.5 Kissei Pharma Recent Developments/Updates
6.5 Gland Pharma
6.5.1 Gland Pharma Corporation Information
6.5.2 Gland Pharma Description and Business Overview
6.5.3 Gland Pharma Dexrazoxane for Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Gland Pharma Dexrazoxane for Injection Product Portfolio
6.5.5 Gland Pharma Recent Developments/Updates
6.6 Eugia Pharma
6.6.1 Eugia Pharma Corporation Information
6.6.2 Eugia Pharma Description and Business Overview
6.6.3 Eugia Pharma Dexrazoxane for Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Eugia Pharma Dexrazoxane for Injection Product Portfolio
6.6.5 Eugia Pharma Recent Developments/Updates
6.7 Hikma Pharma
6.6.1 Hikma Pharma Corporation Information
6.6.2 Hikma Pharma Description and Business Overview
6.6.3 Hikma Pharma Dexrazoxane for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hikma Pharma Dexrazoxane for Injection Product Portfolio
6.7.5 Hikma Pharma Recent Developments/Updates
6.8 Clinigen Group
6.8.1 Clinigen Group Corporation Information
6.8.2 Clinigen Group Description and Business Overview
6.8.3 Clinigen Group Dexrazoxane for Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Clinigen Group Dexrazoxane for Injection Product Portfolio
6.8.5 Clinigen Group Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Corporation Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Dexrazoxane for Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Pfizer Dexrazoxane for Injection Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 Aurobindo Pharma
6.10.1 Aurobindo Pharma Corporation Information
6.10.2 Aurobindo Pharma Description and Business Overview
6.10.3 Aurobindo Pharma Dexrazoxane for Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Aurobindo Pharma Dexrazoxane for Injection Product Portfolio
6.10.5 Aurobindo Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dexrazoxane for Injection Industry Chain Analysis
7.2 Dexrazoxane for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dexrazoxane for Injection Production Mode & Process
7.4 Dexrazoxane for Injection Sales and Marketing
7.4.1 Dexrazoxane for Injection Sales Channels
7.4.2 Dexrazoxane for Injection Distributors
7.5 Dexrazoxane for Injection Customers
8 Dexrazoxane for Injection Market Dynamics
8.1 Dexrazoxane for Injection Industry Trends
8.2 Dexrazoxane for Injection Market Drivers
8.3 Dexrazoxane for Injection Market Challenges
8.4 Dexrazoxane for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
